SLC6A3 and Parkinson disease: A randomized trial by Moreau et al. showed that methylphenidate, an inhibitor of SLC6A3, can reduce the severity of gait hypokinesia and freezing in patients with advanced PD who received subthalamic nucleus stimulation [22].